200,000-440,000 allogeneic retinal pigment epithelial cells expressing recombinant human CNTF -- to the affected eye via a surgical intravitreal implant. Approval was based on results from a pair ...

Our positive results for the Neurotech NT-501 CNTF implant were submitted to the FDA, which approved the treatment for clinical use nationwide in March. We hope to be a major site for this treatment ...

Encelto helps to slow the loss of your photoreceptors through production and release of a protein called recombinant human ciliary neurotrophic factor (CNTF ... 3% of people, implant extrusion ...

The most promising of them, NT-501, is an ocular implant that is able to deliver therapeutic doses of ciliary neurotrophic factor (CNTF) into the retina directly and is able to sustain the doses ...

ENCELTO utilizes an encapsulated cell therapy technology designed to continually deliver therapeutic doses of ciliary neurotrophic factor (CNTF ... of the implant, ENCELTO significantly slowed ...